an analgesic / anti - inflammatory pharmaceutical dosage form which comprises an effective amount of an active ingredient selected from the group consisting of racemic 5 - benzoyl - 2 , 3 - dihydro - 1h - pyrrolizine - 1 - carboxylic acid , optically active forms thereof and pharmaceutically acceptable salts thereof , in combination with a pharmaceutically acceptable excipient or diluent , said dosage form being an intranasally administrable dosage form .